Showing results (41-50 of 89) with videos related to
Sort By:
Pageof 9
Neurology|October 10, 2007
Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infectionA Mellgren, R W Price, L Hagberg, et al.Clinical and Experimental Neurology|January 1, 1987
Neoplastic angioendotheliosisB J Brew, D J O'Sullivan, P Darveniza, et al.Journal of Neurochemistry|October 1, 1992
Increased neopterin levels in brains of patients with human immunodeficiency virus type 1 infectionE G Shaskan, B J Brew, M Rosenblum, et al.Neuropathology and Applied Neurobiology|July 13, 2005
Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampusG J Guillemin, B J Brew, C E Noonan, et al.Journal of Psychiatry & Neuroscience : JPN|December 1, 1991
Pursuit eye movement dysfunction in HIV-1 seropositive individualsJ A Sweeney, B J Brew, J G Keilp, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 20, 2014
Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumabZ Calic, C Cappelen-Smith, S J Hodgkinson, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1994
Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complexB J Brew, M O Paul, G Nakajima, et al.Advances in Experimental Medicine and Biology|March 18, 2000
Kynurenine pathway metabolism in human astrocytesG J Guillemin, S J Kerr, G A Smythe, et al.Neurology|December 31, 1997
Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophagesS J Kerr, P J Armati, L A Pemberton, et al.Infection|February 5, 2013
Raltegravir resistance in the cerebrospinal fluidB Mora-Peris, N E Mackie, D Suan, et al.Pageof 9